Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Pharmedic Pharmaceutical Medicinal Joint Stock Company's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:
2. In Ben Graham's calculation of liquidation value, Pharmedic Pharmaceutical Medicinal Joint Stock Company's accounts receivable are only considered to be worth 75% of book value:
Pharmedic Pharmaceutical Medicinal Joint Stock Company's liquidation value for the quarter that ended in . 20 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Receivables Related Terms
Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Receivables Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Receivables Chart
Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Change In Receivables
Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of ₫0.00 Mil mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a Change In Receivables of ₫0.00 Mil as of . 20. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Receivables too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Change In Receivables is ₫0.00 Mil.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Receivables compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Receivables of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Change In Receivables is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current Change In Receivables of ₫0.00 Mil. The current Change In Receivables is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current Change In Receivables is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, cosmetics, medical supplies, and other products in the health sector. The company's products include Farzincol Bottle, Farzincol Syrup, Sibemag, Vitamin C 50, Vitamin PP 500, Vitamin PP 50, Nacofar, Cooldrop, Inhaler, Povidine 10% 90ml, Povidine 4% 500, Povidine 10% 8ml, and Povidine 4% 800.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:PMC has been successfully added to your 
